SEQUENT.NSE News

In this briefing: India Insurance: Policy reforms continue The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside Chartered Insights: Indian Consumption~ A Decadal Story Aequs Limited: From Aerospace Component Leader to Diversified Precision Platform Axis Bank: A Temporary Shock or A Structural Shift? 1. India Insurance: Policy reforms continue The lower house of the Indian Parliament passed the much awaited “Sabka Bima Sabki Raksha (amendment of Insurance laws) Bill, 2025” yesterday proposing significant changes as well as streamlining of a few provisions The key amendments include 1) 100% foreign direct investment (FDI) in insurance, 2) significant reduction in initial capital requirement for re-insurers, 3) merger between insurance and non-insurance entities, 4) increase in approval thresholds for stake sale in insurers, 5) empowering the insurance regulator to regulate distribution commission payouts, 6) operational flexibility for LICI, and 7) creation of reserve fund by LICI In our view, the newly inserted section 40 (2A) indicates no material changes to the existing payout structure for insurance intermediaries.

In this briefing: Rio Tinto: Reorg Detail, New Guidance Primer: Nestle (NSRGY US) - Dec 2025 VEON (VEON US): Two New Fintech Developments Signal Significant Digital Growth Ahead The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside Chartered Insights: Indian Consumption~ A Decadal Story 1. Rio Tinto: Reorg Detail, New Guidance The reorg will see H1/25 Minerals revenue decline to zero as items are reclassified to Iron Ore and Aluminum/Lithium and Iron/Titanium and Borates are under review Guidance for 2026 indicates a 4.3% and 2.6% yoy increase in iron ore and alumina output, respectively, but a -2.5% and -3.7% decline in bauxite and copper production Rio appears near fully valued, with -3.9% downside to our DCF and 4.5% upside to the consensus target, and we still see downside risk for iron ore and copper prices 2. Primer: Nestle (NSRGY US) - Dec 2025 Dominant Market Position and Brand Portfolio: Nestlé stands as the world's largest food and beverage company, boasting a diversified portfolio of iconic brands with strong consumer loyalty across various product categories and geographic regions.

In this briefing: Primer: Nestle (NSRGY US) - Dec 2025 VEON (VEON US): Two New Fintech Developments Signal Significant Digital Growth Ahead The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside Chartered Insights: Indian Consumption~ A Decadal Story VietNam Holding — Vietnam shaking off the tariff turmoil 1. Primer: Nestle (NSRGY US) - Dec 2025 Dominant Market Position and Brand Portfolio: Nestlé stands as the world's largest food and beverage company, boasting a diversified portfolio of iconic brands with strong consumer loyalty across various product categories and geographic regions. This extensive reach and brand recognition provide a significant competitive advantage and a resilient revenue base. Focus on Innovation and High-Growth Categories: The company is strategically pivoting towards high-growth areas such as nutrition, health, and wellness, alongside pet care and coffee. Significant investment in research and development is fueling innovation in plant-based products, sustainable packaging, and premium offerings to cater to evolving consumer preferences.

In this briefing: VEON (VEON US): Two New Fintech Developments Signal Significant Digital Growth Ahead The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside VietNam Holding — Vietnam shaking off the tariff turmoil Taiheiyo Cement (5233 JP): U.S. Scarcity Assets Drive Activist Re-Rating Potential Aequs Limited: From Aerospace Component Leader to Diversified Precision Platform 1. VEON (VEON US): Two New Fintech Developments Signal Significant Digital Growth Ahead VEON’s JazzCash in Pakistan and China’s Binance are exploring blockchain integration for remittances, merchant settlement, and stablecoin payment rails, with implementation contingent on regulatory approval. VEON’s Banglalink received Bangladesh Bank approval to operate as a payment service provider, enabling instant person-to-person transfers, remittance services, utility payments, merchant transactions, and salary disbursements. VEON can transfer its learnings from Pakistan to Bangladesh to create a new large fintech business that can be on par with the size of the Group’s Pakistan fintech business. 2.

In this briefing: VEON (VEON US): Two New Fintech Developments Signal Significant Digital Growth Ahead The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside Chartered Insights: Indian Consumption~ A Decadal Story VietNam Holding — Vietnam shaking off the tariff turmoil Taiheiyo Cement (5233 JP): U.S. Scarcity Assets Drive Activist Re-Rating Potential 1. VEON (VEON US): Two New Fintech Developments Signal Significant Digital Growth Ahead VEON’s JazzCash in Pakistan and China’s Binance are exploring blockchain integration for remittances, merchant settlement, and stablecoin payment rails, with implementation contingent on regulatory approval. VEON’s Banglalink received Bangladesh Bank approval to operate as a payment service provider, enabling instant person-to-person transfers, remittance services, utility payments, merchant transactions, and salary disbursements. VEON can transfer its learnings from Pakistan to Bangladesh to create a new large fintech business that can be on par with the size of the Group’s Pakistan fintech business. 2.

In this briefing: The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside VietNam Holding — Vietnam shaking off the tariff turmoil Taiheiyo Cement (5233 JP): U.S. Scarcity Assets Drive Activist Re-Rating Potential Aequs Limited: From Aerospace Component Leader to Diversified Precision Platform IWOW Technology - 1H26 Earnings Update - Limited Near-Term Catalysts, but Net Cash Still a Positive 1. The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside The NCLT has approved the Sequent-Viyash merger. The 56:100 swap ratio consolidates two Carlyle-backed entities into an INR 8,000 Cr+ Life Sciences platform. The injection of Viyash’s 9 USFDA facilities and 28% EBITDA margin profile structurally repairs Sequent’s historical profitability issues, creating a diversified CDMO + Animal Health entity. With pro-forma EBITDA running at INR 760 Cr (Annualized) and a management upgrade via Dr. Hari Babu (Ex-Mylan COO), the stock is primed for a re-rating if execution holds. 2.

In this briefing: The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside Chartered Insights: Indian Consumption~ A Decadal Story VietNam Holding — Vietnam shaking off the tariff turmoil Taiheiyo Cement (5233 JP): U.S. Scarcity Assets Drive Activist Re-Rating Potential Aequs Limited: From Aerospace Component Leader to Diversified Precision Platform 1. The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside The NCLT has approved the Sequent-Viyash merger. The 56:100 swap ratio consolidates two Carlyle-backed entities into an INR 8,000 Cr+ Life Sciences platform. The injection of Viyash’s 9 USFDA facilities and 28% EBITDA margin profile structurally repairs Sequent’s historical profitability issues, creating a diversified CDMO + Animal Health entity. With pro-forma EBITDA running at INR 760 Cr (Annualized) and a management upgrade via Dr. Hari Babu (Ex-Mylan COO), the stock is primed for a re-rating if execution holds. 2. Chartered Insights: Indian Consumption~ A Decadal Story India's consumption is the core economic engine , driven by a surge in Per Capita Income and a structural shift toward premium spending.

In this briefing: The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside Chartered Insights: Indian Consumption~ A Decadal Story Aequs Limited: From Aerospace Component Leader to Diversified Precision Platform Axis Bank: A Temporary Shock or A Structural Shift? Milky Mist IPO: A Bet on New Age & Value Added Dairy Products 1. The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside The NCLT has approved the Sequent-Viyash merger. The 56:100 swap ratio consolidates two Carlyle-backed entities into an INR 8,000 Cr+ Life Sciences platform. The injection of Viyash’s 9 USFDA facilities and 28% EBITDA margin profile structurally repairs Sequent’s historical profitability issues, creating a diversified CDMO + Animal Health entity. With pro-forma EBITDA running at INR 760 Cr (Annualized) and a management upgrade via Dr. Hari Babu (Ex-Mylan COO), the stock is primed for a re-rating if execution holds. 2. Chartered Insights: Indian Consumption~ A Decadal Story India's consumption is the core economic engine , driven by a surge in Per Capita Income and a structural shift toward premium spending.

Indian markets experienced a volatile trading session on weekly expiry day, declining by nearly half a percent. This extends the current consolidation phase. Analysts suggest a cautiously optimistic undertone supported by firm domestic macro indicators. Several companies like Groww, HUL, Adani Ports, TCS, and Infosys are in focus due to recent developments and upcoming corporate actions.